UT MD Anderson Cancer Center

UT MD Anderson is one of the world's most respected centers devoted exclusively to cancer patient care, research, education and prevention. Its sole mission is to end cancer for patients and their families around the world.

UT MD Anderson is located in central Houston in the Texas Medical Center and also provides cancer care at several locations throughout the Greater Houston Area and collaborates with hospitals, health systems and organizations across the U.S. and around the world to advance our mission to end cancer. 

UT MD Anderson was created in 1941 as part of The University of Texas System, and, in 1971, it became one of the nation's original three comprehensive cancer centers designated by the National Cancer Act of 1971.

U.S. News & World Report’s “Best Hospitals” rankings has named UT MD Anderson the nation's top hospital for cancer care. The institution has been named one of the nation’s top two hospitals for cancer care every year since the survey began in 1990. 

UT MD Anderson’s people are at the heart of its mission, with almost 27.000 employees, including over 2,000 faculty, working together to advance cancer care, research and education. The institution’s faculty includes nationally recognized leaders, including a Nobel Laureate and members of the National Academy of Medicine and National Academy of Sciences. In FY25, 5,905 trainees participated in educational programs across clinical, nursing and research disciplines, helping prepare the next generation of experts.

Research at UT MD Anderson

At UT MD Anderson, important scientific knowledge gained in the laboratory is rapidly translated into clinical care. With $1.3B invested in research in FY25, more than 140 patents awarded and 70% of all cancer drugs approved by the Food and Drug Administration that year tested here, UT MD Anderson continues to drive progress for patients. 

The institution is home to the world’s largest cancer clinical trials program, providing access to investigational therapies before approval. 

In FY25, UT MD Anderson held seven National Cancer Institute Specialized Programs of Research Excellence grants in brain cancer, gastrointestinal cancer, hepatocellular carcinoma, lymphoma outcomes, melanoma, ovarian cancer and sarcoma, as well as one joint grant with UT Southwestern in lung cancer.